Introduction
Regenerative strategies for inferior bone repair are a growing need in aging people, in which our immediate population demands include slow healing fractures (estimated 1 million patients annually), spine fusions (300 000 surgeries and $18 billion annually) and osteoporotic fractures (704 000 cases annually) (http:// www.boneandjointdecade.org). At present, pharmaceuticals (such as osteoclast inhibitors) and bioactive proteins (such as bone morphogenetic protein-2 (BMP2)) are recognized advancements in bone repair; however, the use of living cell vectors as regenerative treatment for bony disorders offers the advantages of molecular engineering to release both paracrine and autocrine bioactive factors, direct integration of the cells into the regenerative process and a broad diversity of medical applications. [1] [2] [3] [4] Although direct BMP2 gene delivery is shown to promote bone regeneration, [5] [6] [7] the relative potency between gene-and cell-mediated BMP2 deliveries is unknown. Although embryonic and adult mesenchymal stem cells have been extensively studied for cell-mediated gene therapy, 8, 9 other cell sources, such as dermal fibroblasts (DFbs) may be an alternative candidate because of their excellent reprogramming capacity. 10 In fact, DFbs have been differentiated into bone-forming cells by the transduction of osteogenic genes including BMP2, [11] [12] [13] [14] [15] and such genetically modified DFbs have been autologously transplanted to induce ectopic bone formation 14, 15 and promote bone healing in rodent models. 12, 13, 15 In contrast to the use of stem cells, skin cell-mediated therapy is attractive for clinical use because of the relatively less painful harvest technique, low risk of donor site infection or morbidity, less fastidious culture procedure and rapid high cell yield. [12] [13] [14] [15] Therefore, the use of DFb may be considered as one choice of cell type for ex vivo gene therapy, although the osteoinductive capacity may not be superior to stem cells.
The authors' laboratory has demonstrated in separate studies that DFb-mediated 16 and direct adenoviral (Ad) BMP2 gene therapy 7 significantly accelerated cortical long-bone healing in an equine metacarpal/tarsal model, with DFb functioning through endochondral ossification and direct Ad-BMP2 delivery functioning through direct bone formation. Equine bone healing models allowed the comparison of the efficacy of therapeutic methods at multiple sites within the same animal to reduce individual variation, and mimic human osseous injuries and demonstrate the practicality in cost and time efficiency for cell transplantation using large numbers of genetically engineered cells. The study reported herein was designed to use drill hole defects within equine ribs to directly compare the efficacies of these two strategies that were successful in the long bone. Unlike other animal models such as slit osteotomy and critical-size gap ostectomy, [17] [18] [19] the rib drill defect model provides a well-contained area for percutaneous injection, a wellconfined filling defect to quantify bone formation with high resolution, both cortical and cancellous bone healing environments, and permits multiple bone defects per animal for appropriate control groups within the same animal. In addition, the rib drill defect model with a rich cancellous bone environment may be a more receptive environment to exhibit differences in these two methods of BMP2 gene delivery mechanisms, because of the potentially greater numbers of osteoprogenitor cells as receptive targets for paracrine molecular signals of BMP2.
The goal of our study was to use an equine rib drill defect model to evaluate the relative efficacy of DFb-mediated BMP2 and Ad-BMP2 gene delivery to promote bone regeneration. We compared the effects of cell-mediated and direct BMP2 gene delivery using a percutaneous injection of DFbs or viral vectors with and without BMP2 gene transduction. In this model, we demonstrated successfully that an autologous transplantation of BMP2-expressing DFbs and direct Ad-BMP2 induced bone regeneration, and DFb-BMP2 vectors were more potent than a direct vector injection for cortical bone regeneration. Cell-and gene-mediated BMP2 delivery showed equivalent increased bone regeneration in the cancellous bone region and increased bone density in adjacent osseous tissues.
Results

In vitro gene transduction and osteogenic differentiation
Equine DFbs were shown to be permissive to Ad gene transduction, efficiently induced BMP2 protein and successfully differentiated into bone-forming cells in vitro. In six horses, DFbs isolated from skin punch biopsy were successfully transfected by Ad-encoding green fluorescent protein (GFP) or BMP2 gene at 200 MOI (multiplicity of infection) to achieve 480% transduction efficiency (Figures 1a and b) and efficient BMP2 protein production. In the Von Kossa staining performed at 7 days after gene transduction, BMP2-expressing DFb showed mineralized nodule formation (Figures 1d and f) and positive alkaline phosphatase stain (Figures 1e and  g ). There was no nodule formation in DFb-GFP and DFb alone (Figure 1f) , and significantly greater numbers of DFb-BMP2 were positive on the alkaline phosphatase staining than DFb-GFP and DFb alone (Figure 1g ).
Clinical assessment
Equine rib drill defects were treated by subcutaneous injection of Gey's balanced salt solution (GBSS: control), Ad-GFP, Ad-BMP2, DFb alone, DFb-GFP and DFb-BMP2 (Figure 2a ). All injections were administered at 2 weeks after rib drilling, and all rib specimens were harvested at 6 weeks after the injections (Figure 2b ). During this period, all six horses showed good incisional and surgical site healing, and there were no differences in healing of skin, edema and inflammation in subcutaneous or muscular layers between the treatment groups.
Computed tomography
Quantitative computed tomography (qCT) at 6 weeks after injection showed an induction of bone regeneration in equine rib drill defects by direct gene delivery and DFb-mediated BMP2 therapy (Figure 3a) . In the cortical filling zone, bone volume was significantly greater in the Ad-BMP2, DFb-GFP and DFb-BMP2 groups (Figure 3c ), and cortical mineral density was significantly greater in the Ad-BMP2 group (Figure 3d ). In the medullary filling zone, bone volume was significantly greater in the DFb-BMP2 groups (Figure 3e ). Bone density was not changed in any group (Figure 3f ). In the adjacent cortex zone, mineral density was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (Figure 3g ). In the adjacent medullary zone (Figure 3b ), mineral density was significantly greater in the DFb-BMP2 group (Figure 3h ).
Of the 12 ribs used in 6 horses (3 holes per rib, 36 total holes), 5 ribs were fractured at 1 of the 3 drill holes. The treatment assignments of these five fractured drill holes were GBSS (2), Ad-GFP (2) and Ad-BMP2 (1), and none of the drill holes with DFb injections were fractured regardless of the GFP/BMP2 gene transduction. Thus, the risk of fractures in DFb-injected defects (0 out of 18 defects) was significantly lower than in non-DFb-injected defects (5 out of 18 defects) (P ¼ 0.045). Owing to the fracture confounding our bone regeneration outcomes, these five fractured drill defects were not included in qCT and histological evaluation and were treated as missing data points in data analysis. Despite this data exclusion, the computed powers were 40.8 in all outcomes of qCT and histology.
Histological evaluation
Histomorphometry at 6 weeks after treatments showed denser and more mature bone formation and greater mineralizing activity in equine rib drill defects by direct gene delivery and DFb-mediated BMP2 therapy ( Figures  4 and 5 ). In the cortical filling zone (Figure 4a ), the %porosity and %mineralizing area was significantly greater in the DFb-BMP2 group (Figures 4b and c) , and the %lamellar bone composition was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (Figure 4d ). In the medullary filling zone (Figure 4e ), the %porosity was significantly greater in the Ad-BMP2, DFb, DFb-GFP and DFb-BMP2 groups (Figure 4f ), the %mineralizing area was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (Figure 4g ), and the %lamellar bone composition was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (Figure 4h ). In the adjacent cortex zone (Figure 5a ), the mineral apposition rate (MAR), osteon filling period and osteon activation frequency was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (Figures 5b-d) . In the adjacent medullary zone (Figure 5e ), the MAR was significantly greater in the Ad-BMP2, DFb and DFb-BMP2 groups (Figure 5f ), the %mineralizing surface was significantly greater in the Ad-BMP2, DFb, DFb-GFP and Cell-and gene-based therapy for bone healing A Ishihara et al DFb-BMP2 groups (Figure 5g ), and the surface activation frequency was significantly greater in the Ad-BMP2, DFb and DFb-BMP2 groups (Figure 5g ).
In vivo tracking of transplanted DFb
Equine ilium drill defects were treated by subcutaneous injection of GBSS, DFb alone, DFb-GFP and DFb-BMP2 Figure 1 In vitro gene transduction and osteogenic differentiation of equine dermal fibroblast (DFbs). Equine DFbs were seeded in 48-well plates at a density of 5 Â 10 4 cells per well and, 24 h later, the monolayer cells were transfected with adenoviral (Ad) vector encoding bone morphogenetic protein-2 gene (Ad-BMP2) or green fluorescent protein gene (Ad-GFP) at 200 MOI. Successful transgene GFP expression was achieved within 2 days (a) with 84% efficiency (b). Efficient BMP2 production in the culture medium was confirmed by ELISA, with the peak protein secretion at 7 days after gene transduction (c). The Von Kossa staining at day 7 demonstrated the mineralized bony nodule formations in DFb-BMP2, but DFb and DFb-GFP showed no nodule formations (d, f) (*P ¼ 0.001). The alkaline phosphatase (ALP) staining at day 7 demonstrated the significantly greater ALP uptake in DFb-BMP2 compared with DFb and DFb-GFP ( # P ¼ 0.007) (e, g). Data were expressed as mean+s.e.m.
Cell-and gene-based therapy for bone healing A Ishihara et al ( Figure 2 ). An in vivo tracking of transplanted DFb was successful, using the drill hole tissues harvested 2 days after injection. There was significant BMP2 gene upregulation in the drill hole tissues with DFb-BMP2 injection, but there was no significant GFP gene upregulation in the drill hole tissues with DFb-GFP injection (Figure 6a ). The drill hole tissues were digested and seeded in culture dishes. The BMP2 protein concentration in the culture medium was significantly higher in the DFb-BMP2 group than in the GBSS, DFb or DFb-GFP groups (Figure 6b ), and the concentrations were less than the detection limit in all of GBSS, DFb and DFb-GFP-treated drill hole tissues and the 3/6 of DFb-BMP2-treated tissues (Figure 6b ).
Discussion
Skin cell-mediated gene therapy using a single percutaneous injection of DFb genetically modified to secrete BMP2 can accelerate bone healing, which was at least equally and potentially more effective than direct BMP2 gene delivery. In our study, DFb-BMP2-treated defects had greater amount of cortical bone filling and more mature lamellar bone formation than did Ad-BMP2-treated defects. For the same reasons delayed direct vector injection was performed, 17, 20 delayed cell injection into a solid granulation tissue may be advantageous to contain the DFb in the healing site, accumulate secreted growth factors in the local region, target rich host cells by BMP2 and potentially provide a healthy environment for transplanted cells.
Bone regeneration has been induced by both cell and gene vectors, but the potency between two effective dosages and strategies have not yet been compared within the same animal. Our model showed that cell-mediated BMP2 delivery appeared to promote bone regeneration more effectively and extensively than did direct BMP2 gene delivery, at least in this model and at the particular cell/vector dosages used in this study. It is not entirely clear whether the efficacy of DFb-BMP2 is primarily due to the secreted BMP2 affecting endogenous progenitors or a direct contribution of BMP2-expressing DFb for bone regeneration. However, our study identified the bmp2-gene-expressing ( Figure 6a ) and BMP2-protein-secreting DFbs (Figure 6b ) in the injected drill defects at 48 h after transplantation supporting a likely paracrine effect by the secreted BMP2 protein. In addition, the in vitro results of our previous study 16 and the study reported herein (Figures 1d and e) have shown that DFb directly formed mineral and an osteoblast phenotype after Ad-BMP2 transduction, and therefore may directly contribute to bone formation in vivo. Future study using an in vivo cell-tracking technique to verify integration of the transplanted DFb within the regenerated bone is warranted. Moreover, the Figure 2 Experimental models and assignments (a) and protocol (b) of the in vivo study. The rib drill defects were used to demonstrate an acceleration of bone healing by dermal fibroblast (DFb)-based bone morphogenetic protein-2 (BMP2) delivery, and the ilium drill defects were used for an in vivo tracking of transplanted DFb. Using six healthy adult horses, the 8 mm diameter 10-12 mm deep drill hole defects were created bilaterally in the tenth or eleventh ribs (three holes per rib, six holes per horse) and, 2 weeks later, treated by percutaneous injections of Gey's balanced salt solution (GBSS: saline control, n ¼ 6 defects), adenoviral vector encoding green fluorescent protein (GFP) gene (Ad-GFP: 5 Â 10 9 IFU per defect, n ¼ 6), adenoviral vector encoding BMP2 gene (Ad-BMP2, n ¼ 6), DFb with no genetic modification (DFb: 5 Â 10 7 cells per defect, n ¼ 6), DFb with GFP gene transduction (DFb-GFP, n ¼ 6) and DFb with BMP2 gene transduction (DFb-BMP2, n ¼ 6). For fluorescent labeling of bone mineralization activity, calcein was administered intravenously at 3 and 4 weeks after the cell/vector injections. The 8 mm diameter 10-12 mm drill holes were also created in the tuber coxae region of ilium (two holes per side, four holes per horse) at days 40 and, 2 weeks later which was 2 days before the euthanasia, treated by percutaneous injections of GBSSS (n ¼ 6), DFb (n ¼ 6), DFb-GFP (n ¼ 6) and DFb-BMP2. All six horses were euthanized at 6 weeks after the cell/vector injection and the rib specimens and ilium drill hole tissues were harvested for analyses.
Cell-and gene-based therapy for bone healing
A Ishihara et al use of different osteogenic genes such as Runx2, 11 BMP7 13 and Lim mineralization protein-3 15 may further improve the osteoinductive capacity of DFb-mediated gene therapy.
Cell-mediated gene delivery method offers many advantages, because using cells as vectors can permit the manipulation and control of many steps that occur in vivo with direct delivery. First, conditions can be controlled to optimize cell transduction efficiency, plus injecting cells increases cellularity at the repair site. Many viral vectors, and certainly the Ad vector, induces a local tissue inflammation, 21 although the cell injection Figure 3 Computed tomographic (CT) images and quantitative analysis of bone regeneration in equine rib drill defect model. Six skeletally mature horses had surgically created three drill hole defects in the tenth or eleventh ribs bilaterally (three defects per rib; six rib defects per horse). Two weeks after surgery, the six defects were treated with ultrasound-guided percutaneous injections of autologous dermal fibroblasts (DFbs) after BMP2 gene transduction (DFb-BMP2; n ¼ 6 defects), GFP gene transduction (DFb-GFP; n ¼ 6), DFb alone (DFb; n ¼ 6), Ad-BMP2 (n ¼ 6), Ad-GFP (n ¼ 6) or Gey's balanced salt solution (GBSS; n ¼ 6). Quantitative CT of the ribs were performed at 6 weeks after injections.
(a) Cross-sectional (left) and three-dimensional images (right) of the representative rib drill hole defects in each treatment group (scale bars: 1 cm). (b) Schematic images of the four regions evaluated by quantitative CT. In the cortical filling zone, bone volume was significantly greater in the Ad-BMP2, DFb-GFP and DFb-BMP2 groups (c), and cortical mineral density was significantly greater in the Ad-BMP2 group (d). In the medullary filling zone, bone volume was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (e). Bone density was not changed in any group (f). In the adjacent cortex zone, mineral density was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (g). In the adjacent medullary zone, mineral density was significantly greater in the DFb-BMP2 group (h). Data were expressed as mean+s.e.m.
abc Different letters differ significantly (Po0.05). NS: no significant differences among groups.
Cell-and gene-based therapy for bone healing A Ishihara et al might also induce an inflammatory response. In addition to inflammation, activation of the innate immune response by viral vectors is well confirmed, 22, 23 and indeed in horses injected directly with the Ad vector develop detectable serum antibody within weeks. 7 Complicating the potential effectiveness of direct Ad vector delivery would be previous exposure to wild-type adenovirus, the consequence of which would be limited efficacy of the direct vector injection. In total, these advantages of cell-mediated gene therapy may be responsible for the relatively greater bone regeneration capacity shown in DFb-BMP2-treated rib drill defects. Figure 4 Histological evaluation of the cortical and medullary bone filling regions of the rib drill hole defects. Six skeletally mature horses had surgically created three drill hole defects in the tenth or eleventh ribs bilaterally (three defects per rib; six rib defects per horse). Two weeks after surgery, the six defects were treated with ultrasound-guided percutaneous injections of autologous dermal fibroblasts (DFbs) after BMP2 gene transduction (DFb-BMP2; n ¼ 6 defects), GFP gene transduction (DFb-GFP; n ¼ 6), DFb alone (DFb; n ¼ 6), Ad-BMP2 (n ¼ 6), Ad-GFP (n ¼ 6) or Gey's balanced salt solution (GBSS; n ¼ 6). Histological evaluations were performed at 6 weeks after injections. In the cortical filling zone (a) (scale bars: 0.5 mm), the %porosity and %mineralizing area was significantly greater in the DFb-BMP2 group (b, c), and the %lamellar bone composition was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (d). In the medullary filling zone (e) (scale bars: 0.5 mm), the %porosity was significantly greater in the Ad-BMP2, DFb, DFb-GFP and DFb-BMP2 groups (f), the %mineralizing area was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (g), and the %lamellar bone composition was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (h). Data were expressed as mean+s.e.m. Cell-and gene-based therapy for bone healing A Ishihara et al
In equine metacarpal/tarsal bone, DFb-BMP2-treated osteotomies were composed of mature cartilage that did not fully convert to bridging woven bone. 16 The authors speculated that incomplete endochondral ossification may have been caused by the limited number of osteoprogenitor cells in the dominantly cortical bone healing site. Although BMP2 is a key factor for chondrocyte maturation during endochondral ossification, multiple signaling molecules from osteoprogenitor cells such as BMP2, BMP4, BMP6 and BMP7 are involved in the apoptosis of hypertrophic chondrocytes. 24 We speculate that the intramedullarly delivered DFb-BMP2 may work synergistically with host osteoprogenitor cells present in the cancellous bone environment and efficiently complete the endochondral ossification process. The rib also has such a large population of host osteoblastic lineage that may serve as a target for the secreted BMP2 from the transplanted DFb to induce bone regeneration.
It is important to point out that direct BMP2 gene delivery was still an effective strategy for bone regeneration. In agreement with our previous studies, 7,17 delayed vector injection (2 weeks after surgery) into the mature granulation tissue seemed to be supportive of an effective outcome, presumably by viral containment, growth factor accumulation and gene transduction to a large receptive host cell population. 7, 17 There is always a dilemma in accurately calculating an in vivo transduction efficiency (that is, number of viral particles per cell) and vector/cell dissemination (that is, local tissue distribution). The numerous physical factors in vivo, including regional blood flow or lymphatic drainage, tissue solidity, as well as type and concentration of native cells at the treatment site, make an in vivo transduction Figure 5 Histological evaluation of the adjacent cortex and medulla regions of the rib drill hole defects. Six skeletally mature horses had surgically created three drill hole defects in the tenth or eleventh ribs bilaterally (three defects per rib; six rib defects per horse). Two weeks after surgery, the six defects were treated with ultrasound-guided percutaneous injections of autologous dermal fibroblasts (DFbs) after BMP2 gene transduction (DFb-BMP2; n ¼ 6 defects), GFP gene transduction (DFb-GFP; n ¼ 6), DFb alone (DFb; n ¼ 6), Ad-BMP2 (n ¼ 6), Ad-GFP (n ¼ 6) or Gey's balanced salt solution (GBSS; n ¼ 6). Histological evaluations were performed at 6 weeks after injections. In the adjacent cortex zone (a) (scale bars: 0.5 mm), the mineral apposition rate, osteon filling period and osteon activation frequency was significantly greater in the Ad-BMP2 and DFb-BMP2 groups (b-d). In the adjacent medullary zone (e) (scale bars: 0.5 mm), the mineral apposition rate was significantly greater in the Ad-BMP2, DFb and DFb-BMP2 groups (f), the %mineralizing surface was significantly greater in the Ad-BMP2, DFb, DFb-GFP and DFb-BMP2 groups (g), and the surface activation frequency was significantly greater in the Ad-BMP2, DFb and DFb-BMP2 groups (h). Data were expressed as mean+s.e.m.
abc Different letters differ significantly (Po0.05).
Cell-and gene-based therapy for bone healing A Ishihara et al efficiency, at best, a good estimate of the MOI at the injection site. In addition, the well-confined drill hole area should provide adequate vector containment, and the presence of highly cellular bone marrow tissue adjunct to the drill hole should be beneficial to provide sufficient host progenitor cells for efficient gene transduction. An advantage of direct gene therapy is the less complexity of vector preparation, as opposed to cellmediated therapy, but can involve a risk of innate immune reaction or an increase in neutralizing antibody, which may prohibit multiple vector injections in the same individual. In the clinical setting, single direct Ad-BMP2 treatment may be applied to an orthopedic patient without the need to wait for sufficient numbers of autologous cells to be prepared for cell-mediated BMP2 therapy.
Our results indicated that placing DFbs in the medullar cavity by itself may be beneficial to facilitate bone regeneration. In this study, the volume of medullary filling was greater in all DFb-treated bone defects, regardless of the BMP2 gene transduction (that is, all of DFb, DFb-GFP, DFb-BMP2) compared with saline control (Figures 4e and f) . This result may suggest that the cancellous bone environment may provide the differentiation factors and three-dimensional architecture, such that DFbs could sufficiently undergo osteogenic differentiation. Possibly, the transplanted DFbs synthesized the extracellular matrix to support the migration of host osteoprogenitor cells. DFbs have been shown to produce cartilage-like dense extracellular matrix when cultured in osteogenic-induction medium, 25, 26 which may serve as a biological scaffold to stimulate recruitment of osteoprogenitor cells from the surrounding cancellous bone or promote endochondral ossification. In this regard, DFb-mediated BMP2 therapy may be considered to have a dual osteoinductive and osteoconductive effect; therefore, possibly, the simultaneous injection of DFbs and stem cells would promote greater bone regeneration than the use of an individual cell type.
To the authors' knowledge, this is the first study reporting the increased osteon/surface activation frequency by gene-or cell-mediated BMP2 delivery (Figures 5d and h) . Activation of bone remodeling is initiated as an osteoclastogenesis, not osteoblastogenesis, and therefore is not considered as a primary function of BMPs. However, in recent years, new roles of BMPs associated with osteoclasts have been discovered, including a recruitment of monocytic precursor cells, 25 stimulation of osteoclastic differentiation 27 and facilitating the transition from bone resorption to bone formation phases as coupling factors. 24 In addition, BMP2 has been shown to activate hematopoietic cells of murine bone marrow resulting in an upregulation of osteoclast differentiation factor and enhanced osteoclast-like multinucleated cell formation. 28 Recruitment of hematopoietic cells and conversion of these precursors into osteoclasts are important processes in the initiation phase of bone remodeling. 29 Therefore, in our study, the intramedullarly delivered BMP2 may stimulate the hematopoietic precursors present in the rib marrow cavity and activate bone turnover of the adjacent cortex and medulla. As BMP2 may have a role in coordinating the functional connection between osteoclastic and osteoblastic activities as a coupling factor, 29 the increase in bone resorption could be tightly orchestrated with subsequent bone formation ensuring an anabolic bone remodeling. One of the potential clinical applications of this aspect is bone fragility disorders such as osteoporosis, because encouraging anabolic remodeling in specific long bones may be a more physiological method to improve bone mineral density than shutting down systemic bone turnover.
In vivo cell tracking successfully identified the functional presence of our injected cells in the granulation tissue bed. We chose to harvest the ilium drill hole tissue 2 days after the DFb transplantation. Our results showed that percutaneously transplanted DFb-BMP2 were present at the recipient site, maintained BMP2 transgene expression and local BMP2 production, at least when the cells were retrieved and re-cultured (Figure 6 ), The DFb-GFP-treated drill hole tissue also had higher GFP Figure 6 In vivo tracking of transplanted dermal fibroblasts (DFbs). Six skeletally mature horses had surgically created two drill hole defects in the tuber coxae aspect of the ilium bilaterally (two defects per side; four ilium defects per horse). Two weeks after surgery, the four defects were treated with ultrasound-guided percutaneous injections of autologous DFbs after BMP2 gene transduction (DFb-BMP2; n ¼ 6 defects), GFP gene transduction (DFb-GFP; n ¼ 6), DFb alone (DFb; n ¼ 6) or Gey's balanced salt solution (GBSS; n ¼ 6). The drill hole tissues were harvested at 2 days after injections. There was significant BMP2 gene upregulation in the drill hole tissues with DFb-BMP2 injection (*P ¼ 0.003) (a), but there were no significant GFP gene upregulation in the drill hole tissues with DFb-GFP injection (NS: no significant differences) (panel a). The drill hole tissues were digested and seeded in culture dishes. The BMP2 protein concentration in the culture medium was significantly higher in the DFb-BMP2 group than in the GBSS, DFb or DFb-GFP groups ( # P ¼ 0.001) (panel b), and the concentrations were less than the detection limit in all of GBSS, DFb and DFb-GFP-treated drill hole tissues and the 3/6 of DFb-BMP2-treated tissues (ND: not detected) (panel b). Data were expressed as mean+s.e.m.
A Ishihara et al transgene expression than did DFb or DFb-BMP2. The BMP2 gene transduction could be supportive for cell viability, so that more number of DF-BMP2 than DFb-GFP might survive. Cultures of stem cells engineered to express BMP2 outlive the cells transduced with marker genes and appeared more robust and morphologically healthy. It is also possible that, because a significantly greater GFP expression was not detected in the DFb-GFP-treated tissues, an active bone healing environment may be more favorable for the DFb to sustain BMP2 expression than GFP expression.
Materials and methods
Ad vector production
Recombinant, replication-deficient, serotype-5 Ad vectors containing either a 1547 base-pair open reading frame segment of human BMP2 (Ad-BMP2) or GFP (Ad-GFP) under the control of the cytomegalovirus promoter were generated. 16, 17 The expression of transgenes was verified in cell culture. 8 
Experimental design
Six skeletally mature horses (weighing 445-550 kg) were used to isolate DFbs by full-thickness skin punch biopsy. In vitro gene transduction and osteogenic differentiation were confirmed in DFbs from all six horses. The in vivo study used the same six horses in two separate experiments; (1) rib drill hole defects for an assessment of bone regeneration and (2) ilium drill hole defects for an in vivo cell tracking (Figure 2 ). All procedures were approved by the Institutional Laboratory Animal Care and Use Committee at The Ohio State University.
At day 0, the same six horses had surgically created three drill hole defects in the tenth or eleventh ribs bilaterally (three defects per rib; six rib defects per horse) (Figure 2a ). Skin biopsy was performed 2 weeks before the rib drilling (day 14) to culture sufficient DFbs for injection. For each horse, the six rib drill hole defects were treated with percutaneous injection of autologous DFbs after BMP2 gene transduction (DFb-BMP2; n ¼ 6 defects), GFP gene transduction (DFb-GFP; n ¼ 6), DFb alone (DFb; n ¼ 6), Ad-BMP2 (n ¼ 6), Ad-GFP (n ¼ 6) or GBSS (n ¼ 6) (Sigma-Aldrich, St Louis, MO, USA). The six defects in each horse were assigned in a block design to rotate these injections. All injections were administered 2 weeks after surgery (day 14). Six weeks after the injection (day 56), the horses were euthanized and rib specimens were harvested. Efficacy was assessed by qCT and histology.
Using the same six horses, two drill hole defects were also created bilaterally on the tuber coxae of the ilium (two defects per side, four ilium defects per horse). Separate skin biopsies were performed 2 weeks before the ilium drilling (day 26) to culture sufficient DFbs. For each horse, the four ilium drill hole defects were treated with percutaneous injection of DFb-BMP2 (n ¼ 6 defects), DFb-GFP (n ¼ 6), DFb (n ¼ 6) or GBSS (n ¼ 6). The four defects in each horse were assigned in a block design to rotate these injections. The drill defects were created at day 40 of the experiment, the injections were administered at day 54 (2 weeks after drilling) and the horses were euthanized at day 56; therefore, the tissues within the ilium drill holes were harvested 2 days after the injection. The ilium defect tissues were processed for the PCR to detect BMP2/GFP gene expression and the collagenase digestion to culture BMP2-secreting or GFP expressing DFb.
DFb isolation and in vitro osteogenic differentiation
Full-thickness skin tissue was harvested using a 5-mm diameter biopsy punch from the pectoral region (10-12 punches per horse) from each of the six horses. The dermal layer was dissected from the epidermis under a microscope, and DFbs were isolated by type-1 collagenase digestion (GIBCO, Grand Island, NY, USA) and cultured in Dulbecco's modified Eagle's medium supplemented with L-glutamine (300 mg ml 7 IFU per well) (Adeno-X Rapid Titer Kit; Clontech, Mountain View, CA, USA). Two and seven days after gene transduction, gene transduction efficiency was quantified by fluorescent microscopy, and BMP2 protein production confirmed with ELISA (enzyme-linked immunosorbent assay; R&D Systems, Minneapolis, MN, USA). Seven days after gene transduction, osteogenic differentiation of DFb was quantified by the number of Von Kossa-positive mineralized bony nodules within the well and the intensity score of alkaline phosphatase (Sigma-Aldrich) staining in three representative Â 100 microscopic fields per well using the following grading scheme: 0 (0% of cells in the field showing stain uptake), 1 (1-25%), 2 (26-50%), 3 (51-75%) and 4 (76-100%).
Rib drill hole defect model
The rib drill hole defects were used to evaluate the relative efficacy of direct gene-and DFb-mediated BMP2 delivery to induce bone regeneration. Skin punch biopsy was performed at 2 weeks before the rib drilling (day 14). At day 0, general anesthesia was induced by xylazine (Rompun; Bayer, Pittsburgh, PA, USA; intravenously (i.v.), 1.1 mg kg ) and maintained by Isoflurane (IsoFlo; Abbott, Parsippany, NJ, USA; infusion, 2-5%). After aseptic preparation of the bilateral lateroventral thorax, 4-cm stab incisions were made through the skin and external and internal abdominal oblique muscles, and a low-speed cordless electric drill was used to create 8-mm diameter 10-mm deep defects on the tenth or eleventh ribs bilaterally. Three drill holes were made in each rib at 10-cm apart (that is, 6 rib defects per horse), and the most ventral hole was created at 20-cm dorsal from the costochondral junction. Efforts were made to create drill holes in the middle of the ribs. The three drill hole defects in each rib were created by three separate stab incisions to prevent the periosteal communication between the defects, and were thoroughly flushed with sterile saline solution to remove all bone shards. Antibiotics were administered for 1 day after surgery (procaine penicillin (Crystacillin; Solvay, Cell-and gene-based therapy for bone healing A Ishihara et al Marietta, GA, USA; intramuscularly, 22 000 IU kg
À1
) and gentamicin (Gentocin; Schering, Kenilworth, NJ, USA; i.v., 6.6 mg kg À1 )); the anti-inflammatory drug (phenylbutazone (Butazolidin; Schering; orally, 4.4 mg kg
) was administered for 3 days after surgery.
One week after the surgery (day 7), DFbs were seeded in 18 large culture flasks (75-cm 2 ; 3 Â 10 6 cells per flask). On day 12, 2 days before injection, the DFbs (80-90% confluent) were treated with Ad-BMP2 (DFb-BMP2; 6 flasks), Ad-GFP (DFb-GFP; 6 flasks) or untreated (DFb; 6 flasks). The total cell number at this time point was estimated at 1 Â 10 7 DFb per flask based on a pilot trial and hemacytometer counting (Hausser Scientific, Horsham, PA, USA). Ad-BMP2/GFP were administered at 200 MOI; therefore, 2 Â 10 9 IFU of vector was administered in each flask.
Two weeks after the surgery (day 14), 48 h after DFb gene transduction, cells were harvested by trypsinization (GIBCO), counted by hematocytometer, centrifuged and resuspended into a 500 ml total volume with GBSS containing 5 Â 10 7 cells for each of DFb, DFb-GFP and DFb-BMP2. All cell injections were completed within 60-90 min after trypsinization. Moreover, the Ad-GFP and Ad-BMP2 vectors were diluted into a 500 ml total volume with GBSS containing 5 Â 10 9 IFU. Horses were placed under general anesthesia, and the assigned rib defects were treated by percutaneous ultrasound-guided (Technos MPX, Esaote S.p.A, Genoa, Italy) needle injection of 5 Â 10 7 cells of DFb-BMP2, DFb-GFP, DFb, or 5 Â 10 9 IFU of Ad-GFP or Ad-BMP2, or GBSS in a 500 ml volume directly into the drill hole defects. For fluorescent labeling of bone mineralization activity, calcein (Sigma-Aldrich) was administered at a rate of 20 mg kg
, dissolved in 2% sodium bicarbonate solution (Abbott Laboratories, North Chicago, IL, USA) i.v. at 3 and 4 weeks after the DFb injection (days 35 and 42, respectively).
Quantitative computed tomography
Six weeks after the cell/vector rib injection (day 56), horses were sedated with xylazine and euthanized by lethal i.v. overdose of pentobarbital (Beuthanasia; i.v., 2.2 mg kg À1 ). Immediately after the euthanasia, the ribs with drill hole defects were dissected. qCT (Picker PQS Helical CT Scanner; Philips Medical Systems, N.A., Bothell, WA, USA) was performed in the transverse plane (perpendicular to the rib axis) at 1-mm contiguous slices to evaluate bone regeneration. The entire drill hole defect, along with 1.5 cm margins dorsal and ventral, was imaged. Two-dimensional images in the coronal plane (perpendicular to the drill hole axis) were created using an image analysis software (Mimics, Materialise, Ann Arbor, MI, USA). The coronal sections allowed visualizing the cross-sectional area of cylinder drill hole defects and using the 8-mm diameter circular region of interest (ROI) to trace the original size of the drill hole. Three central coronal slices across the cortical zone were selected, and the volume and mineral density of cortical bone filling was calculated within the 8-mm diameter circular ROIs positioned at the center of the remaining defect. Using the same three coronal slices, the mineral density of adjacent cortex was also calculated within four of the 4-mm diameter circular ROIs concentrically positioned at 8-mm away from the center of the remaining defect. The threshold level of 600-3000 HU (Hounsfield units) was used for cortical filling and adjacent cortex zones to trace 'compact' bone but exclude 'spongial' bone, and fibrous, muscle and fat tissues (Mimics software tutorial manual; Materialise). Similarly, three central coronal slices across the medullar zone were selected, and the volume and mineral density of medullary bone filling was calculated within the 8-mm diameter circular ROIs positioned at the center of the remaining defect. Using the same three coronal slices, mineral density of the adjacent medulla was calculated within four of the 4-mm diameter circular ROIs concentrically positioned at 8-mm away from the center of the remaining defect. The threshold level of 150-3000 HU was used for medullary filling and adjacent medulla zones to trace both 'compact' and 'spongial' bone but exclude fibrous, muscle and fat tissues (Mimics software tutorial manual; Materialise). All HU values were converted to mineral density using potassium phosphate standards (CT Calibration Phantom; Mindways Software Inc., San Francisco, CA, USA).
Histological evaluation
Calcified rib specimens were dehydrated in alcohol, embedded in methylmethacrylate, cut into 10-mm sections in the transverse plane perpendicular to the longitudinal axis at the center of the drill hole and stained with Masson's Trichrome. The rib specimens were evaluated semi-quantitatively for four regions: cortical filling zone, medullary filling zone, adjacent cortex and adjacent medulla (Figure 2) .
The cortical filling zones were evaluated for the porosity (%unfilled area), maturity (%composition of immature woven, mature lamellar bone and mixture within the filled area) and mineralization activity (%calcein-labeled area within the filled area), by point counting with the microscopic grids under Â 200 magnification. The five representative areas in the cortical bone filling in o5-mm depth from the top of drill hole were evaluated and averaged.
Similarly, the medullary filling zones were evaluated for the porosity, maturity and mineralization activity, by point counting with the microscopic grids under Â 200 magnification. The five representative areas of the medullary bone filling in o10-mm depth from the top of drill hole were evaluated and averaged.
The adjacent cortices were evaluated for the MAR, osteon filling period and osteon activation frequency. Within the 1-mm 2 cortical bone area under Â 200 magnification, the number of single-labeled osteon (sL.On) and double-labeled osteon (dL.On) were counted and, in the 2-3 representative dL.On within the 1-mm 2 area, the radii of Haversin canal (Hv.Rd), inner label (In.Rd), outer label (Out.Rd) and cement line (Cm.Rd) were measured using the microscopic grids, and these values were used for the following calculations. Cell-and gene-based therapy for bone healing A Ishihara et al
The five representative areas of the adjacent cortex in o5-mm distance from the edge of drill hole were evaluated and averaged. The adjacent medullae were evaluated for the MAR, percent active bone surface (BS) and surface activation frequency. Within the 1-mm 2 medullar bone area under Â 200 magnification, the trabecula width (Tr.Wd) and the distance between two calcein labels (Lb.Dt) were measured in the 2-3 double-labeled surface and averaged; the intercept counting of total BS and single-/double-labeled MS (mineralizing surface) were performed with the microscopic grids, and these values were used for the following calculations. 32, 33 MARðmm per dayÞ ¼ ðLb:DtÞ Ä 7
Percent mineralizing surface ¼ ðMS=BSÞÂ100
Surface activation frequencyðper yearÞ ¼ ½MARÂðMS=BSÞ Ä Tr:WdÂ365
The five representative areas of the adjacent medulla in o5-mm distance from the edge of drill hole were evaluated and averaged.
Ilium drill hole defect model
The ilium drill hole defects were used for in vivo cell tracking. Skin punch biopsy was performed at day 26 to culture the efficient DFb. At day 40, the drill hole defects were created bilaterally in the tuber coxae regions of ilium as standing surgery. The horses were restrained in stocks, sedated with xylazine (i.v., 1.1 mg kg
À1
), and the skin overlying the tuber coxae was aseptically prepared and injected with local anesthesia (lidocaine; subcutaneous, 100 mg). Stab incisions of 2 cm were made on the lateral aspect of the tuber coxae, and a low-speed cordless electric drill was used to create 8-mm diameter 10-mm deep defects on the tuber coxae. Two drill holes were made in each tuber coxae at 10-cm apart (that is, four ilium defects per horse). The two drill hole defects in each side were created by the two separate stab incisions to prevent the periosteal communication between the defects, and were thoroughly flushed with sterile saline solution to remove all bone shards. Antibiotics and antiinflammatory drugs were administered at the same dose and length as the rib drilling. All procedures were approved by the Institutional Laboratory Animal Care and Use Committee at The Ohio State University.
The DFbs were prepared by the same protocol as for the rib injection. The DFbs were seeded in 18 flasks at day 47 (1 week after ilium drilling), treated with Ad-BMP2, Ad-GFP or untreated at day 52, and harvested and resuspended into a 500 ml total volume with GBSS containing 5 Â 10 7 cells for each of DFb, DFb-GFP and DFb-BMP2 at day 54 (48 h after gene transduction). Horses were restrained in stocks, sedated, aseptically prepared, and the assigned ilium defects were treated by percutaneous ultrasound-guided needle injection of 5 Â 10 7 cells of DFb-BMP2, DFb-GFP, DFb or GBSS in a 500 ml volume directly into the drill hole defects. The drill hole size and the cell dosage of DFb-BMP2, DFb-GFP and DFb were exactly same as the rib drill hole defects making these two model comparable.
Immediately after the euthanasia at day 56 (2 days after the cell injection), the tissue within the ilium drill hole defects were aseptically harvested. The RNA was extracted from the half of the tissue by Trizol technique and the other half were digested by collagenase for 6 h. Transgene expression of human BMP2 and GFP were quantified by SYBR real-time reverse transcriptase-PCR with the ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). Mean fold change was calculated using custom-designed primers for the hbmp2 (forward: 5 0 -AAAACGTCAAGCCAAACA CAAA-3 0 , reverse: 5 0 -GTCACTGAAGTCCACGTACAA AGG-3 0 ) and gfp gene (forward: 5 0 -CATGATATAGACG TTGTGGCTGTTG-3, reverse: 5 0 -AAGCTGACCCTGAA GTTCATCTGC-3 0 ) in the DFb, DFb-GFP and DFb-BMP2-treated drill hole tissue relative to expression of GBSStreated drill hole tissue and relative to expression of the endogenous equine b-actin gene (forward: 5 0 -GGGCAT CCTGACCCTCAAG-3 0 , reverse: 5 0 -TCCATGTCGTCCC AGTTGGT-3 0 ) using the 2 ÀDDCT method. 34, 35 The digested tissues were centrifuged, washed with GBSS and seeded in 25-cm 2 culture flasks (day 57). Four days later (day 61), the culture medium was collected for the detection of BMP2 protein by ELISA. The lowest BMP2 standard (62.5 pg ml
) was considered as detection limit, because the mean ± 2 s.d. optical density in triplicate wells did not overlap that of zero standard (0 pg ml
).
Statistical analysis
Repeated-measure ANOVA (analysis of variance) (SAS Institute Inc., Cary, NC, USA) was used to evaluate the effects of DFb-mediated BMP2 therapy with the post-test multiple comparisons between the treatment groups using Proc Mixed statistical models for continuous outcomes (that is, Von Kossa bony nodule count, qCT, histological evaluation, reverse transcriptase-PCR gene expression and ELISA BMP2 concentration data) and Genmod statistical models for categorical outcomes (that is, alkaline phosphatase stain uptake score). Repeated variables were considered to be nested within horses, and the distribution of data was assessed by the use of a subset of normality tests (such as the Shapiro-Wilk, Kolmogorov-Smirnov, Cramer-von Mises and AndersonDarling tests). Fisher's exact tests were used to compare the frequency outcomes (that is, the occurrence of fractures in rib drill hole defects) between the treatment groups. Significant level was set at Po0.05 for all analyses. Power calculations were made using means, s.d, sample sizes and 5% a-error level for all outcomes differed significantly in given treatment groups.
